Specifications TableSubject area*Chemistry*More specific subject area*Synthetic chemistry, spectroscopy*Type of data*FTIR spectra, NMR spectra, UV spectra, graph, table,*How data was acquired*CHNS Analyzer Flashea 1112 series, FTIR Perkin Elmer Spectrum 100 and the spectra was recorded in range of 4000-*400 cm^−1^*utilizing potassium bromide (KBr) pellet, Spectrophotometer Shimadzu UV-1800, Bruker Avance II 400 spectrometer was used to record the*^*1*^*H and*^*13*^*C Nuclear Magnetic Resonance*Data format*JPEG, Tiff (Raw)*Experimental factors*Streptomycin (Abtek Biologicals Ltd) was used as the positive control while methanol served as negative control.*Experimental features*All chemicals used were commercially available and used as received without purification.*Data source location*Universiti Malaysia Terengganu*Data accessibility*Data is included with this article*Related research article*M.A. Kadir, R. Ramli, M.S.M. Yusof, N. Ismail, N. Ngah, Synthesis, Spectroscopic Studies and Antibacterial Activity of New Lauroyl Thiourea Amino Acid Derivatives, Asian Journal of Chemistry 28 (2016) 596--600.* \[[@bib1]\]**Value of the Data**•The proposed synthetic methods is facile and highly recommended for the synthesis of new thioureido derivatives.•Thioureido derivatives with long alkyl chains have good potential for use in pharmacological area mainly as antibacterial and anticancer agents.•The spectroscopic data information can be manipulated for advanced molecular studies of biological active molecules.

1. Data {#sec1}
=======

Reaction of lauroyl chloride, ammonium thiocyanate and amino acids has led to formation of four new thioureido derivatives namely (3-dodecanoyl-thioureido)propionic acid (R1), 2-(3-dodecanoyl-thioureido)-3-methyl butyric acid (R2), (3-dodecanoyl-thioureido)acetic acid (R3) and 2-(3-dodecanoyl-thioureido)-3-phenyl propionic acid (R4) ([Fig. 1](#fig1){ref-type="fig"}). This reaction involves nucleophilic substitutions (SN2), in order to produce lauroyl isothiocyanate as intermediate, before being charged with amino acids \[[@bib1]\]. All four compounds were fully characterized by common spectroscopic techniques such as Fourier Transform Infrared (FT-IR), ^1^H and ^13^C Nuclear Magnetic Resonance (NMR) and UV-Visible ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}). Elemental analysis and spectroscopic data are listed in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, respectively. Inhibition diameter of the ligands are illustrated in [Fig. 6](#fig6){ref-type="fig"}.Fig. 1The structure of R1, R2, R3 and R4.Fig. 1Fig. 2FTIR spectra of (a) R1 (b) R2 (c) R3 (d) R4.Fig. 2Fig. 3UV spectra of (a) R1 (b) R2,(c) R3,(d) R4 in methanol solution.Fig. 3Fig. 4^1^H NMR spectra for (a) R1 (b) R2 (c) R3 and (d) R4.Fig. 4Fig. 5^13^C NMR spectra of (a) R1, (b) R2, (c) R3, (d) R4.Fig. 5Table 1Elemental analysis (%) of elements present in the compound.Table 1CompoundCHNSR158.109.028.289.54(58.15)(9.15)(8.48)(9.70)R260.259.477.758.77(60.30)(9.56)(7.81)(8.94)R356.518.848.709.98(56.93)(8.92)(8.85)(10.13)R464.798.346.787.80(64.99)(8.43)(6.89)(7.89)[^1]Table 2Summary of the absorption data for R1-R4.Table 2Compound/Stretching*ν* (N--H) str (cm^−1^)*ν* (OH) str (cm^−1^)*ν* (C=O) ~COOH~ str (cm^−1^)*ν* (C=O) NH~2~ str (cm^−1^)*ν* (C--N) str (cm^−1^)*ν* (C=S) str (cm^−1^)R1NH overlap with OH at 3291 (m)1695 (s)1634 (s)1233 (m)720 (m)R2NH overlap with OH at 3332 (m)1712 (s)1650 (s)1236 (m)723 (w)R3NH overlap with OH 3317 (m)1701 (s)1645 (s)1249 (s)719 (m)R4NH overlap with OH at 3314 (m)1710 (s)1692 (s)1248 (s)698 (m)Table 3UV-Vis data for R1-R4.Table 3Wavelength, (nm)AbsorbanceAssignmentR1271.000.250 (*ε* = 1650 M^−1^cm^−1^)n-π\* & π-π\* (C=O)\
n-π\*(C=S)R2272.000.577 (*ε* = 5770 M^−1^cm^−1^)n-π\* & π-π\* (C=O)\
n-π\*(C=S)R3269.000.194 (*ε* = 330 M^−1^cm^−1^)n-π\* & π-π\* (C=O)\
n-π\*(C=S)R4275.5000.416 (*ε* = 4160 M^−1^cm^−1^)n-π\* & π-π\* (C=O)\
n-π\*(C=S)\
π-π\* (p-band aryl)Table 4^1^H NMR data of R1, R2, R3 and R4.Table 4CompoundMoietiesChemical Shift, *δ*~H~ (ppm)R1(3H, t, *J* = 7.35 Hz, CH~3~)0.85(4H, m, *J* = 6.65 Hz, 2 × CH~2~)1.43--1.48(4H, m, *J* = 5.13 Hz, 2 × CH~2~)2.00--2.03(4H, m, *J* = 7.7 Hz, 2 × CH~2~)2.17--2.19(2H, m, *J* = 7.23 Hz, CH~2~)2.33--2.36(4H, m, *J* = 8.57 Hz, 2 × CH~2~)2.57--2.59(2H, t, *J* = 6.30 Hz, CH~2~)2.98(2H, t, *J* = 5.95 Hz, CH~2~)3.20(2H, t, *J* = 6.3 Hz, CH~2~)3.82(1H, t, *J* = 5.6 Hz, NH)7.84(1H, s, NH)10.81(1H, s, OH)11.12R2(3H, t, *J* = 7.0 Hz, CH~3~)0.89(6H, d, *J* = 7.0 Hz, 2 × CH~3~)0.97(2H, m, *J* = 7.0 Hz, CH~3~)1.09--1.13(6H, m, *J* = 5.8 Hz, 3 × CH~2~)1.20--1.25(2H, m, *J* = 7.9 Hz, CH~2~)1.64--1.69(8H, m, *J* = 5.2 Hz, 4 × CH~2~)2.34--2.40(1H, m, *J* = 4.4 Hz, CH)2.46--2.48(2H, t, *J* = 3.4 Hz, CH~2~)4.60--4.80(1H, d, *J* = 4.2 Hz, CH)4.99(1H, d, *J* = 8.4 Hz, NH)6.13(1H, s, NH)9.16(1H, s, OH)11.03R3(3H, t, *J* = 7.00 Hz, CH~3~)0.85(4H, m, *J* = 7.00 Hz, 2 × CH~2~)1.49--1.51(6H, m, *J* = 7.35 Hz, 3 × CH~2~)2.09--2.11(6H, m, *J* = 7.35 Hz, 3 × CH~2~)2.17--2.19(2H, m, *J* = 5.13 Hz, CH~2~)2.31--2.33(2H, t, *J* = 5.6 Hz, CH~2~)3.71(2H, s, CH~2~)4.26(1H, t, *J* = 5.95 Hz, NH)8.09(1H, s, NH)9.33(1H, s, OH)9.65R4(7H, m, *J* = 4.2 Hz, CH~3~ + 2 × CH~2~)0.84--0.87(2H, m, *J* = 7.0 Hz, CH~2~)1.07--1.11(2H, m, *J* = 6.3 Hz, CH~2~)1.35--1.39(2H, m, *J* = 7.0 Hz, CH~2~)1.47--1.51(2H, m, *J* = 6.0 Hz, CH~2~)2.00--2.03(2H, m, *J* = 6.6 Hz, CH~2~)2.32--2.36(2H, m, *J* = 7.9 Hz, CH~2~)2.81--2.84(2H, m, *J* = 6.3 Hz, CH~2~)3.03--3.06(2H, t, *J* = 7.0 Hz, CH~2~)3.10(2H, d, *J* = 3.5 Hz, CH~2~)4.42(1H, t, *J* = 6.3 Hz, CH)5.05(5H, m, *J* = 7.7 Hz, Ar-H)7.14--7.28(1H, d, *J* = 7.7 Hz, NH)8.09(1H, s, NH)10.97(1H, s, OH)11.28Table 5^13^C NMR data of R1, R2, R3 and R4.Table 5CompoundMoietiesChemical shift *δ*~C~, (ppm)R1(CH~3~)14.41(CH~2~)22.56(CH~2~)25.71(6 × CH~2~)29.08--29.49(CH~2~)31.76(CH~2~--C=O)34.39(CH~2~--COOH)35.16(CH~2~--NH)35.74(C=O--OH)172.72(C=O--NH)173.37(C=S)174.97R2(2 × CH~3~)14.17(CH~3~)17.70(CH~2~)19.02(CH~2~)24.70(CH~2~)25.77(5 × CH~2~)29.23--29.59(CH~2~)31.72(CH)34.48(CH~2~--CO)36.64(CH--NH)57.21(C=O--OH)174.19(C=O--NH)176.44(C=S)179.94R3(CH~3~)14.42(CH~2~)22.56(CH~2~)24.95(CH~2~)25.64(4 × CH~2~)29.06--29.48(CH~2~)31.76(CH~2~)34.12(CH~2~--C=O)35.52(CH~2~--COOH)40.96(C=O--OH)171.90(C=O--NH)173.08(C=S)174.98R4(CH~3~)14.37(CH~2~)22.60(CH~2~)25.60(6 × CH~2~)29.23--29.52(CH~2~)31.81(CH~2~--CO)34.12(CH~2~-Ar)37.22(CH--NH)53.69(C~6~H~5~)126.69--138.25(C=O--OH)172.58(C=O--NH)173.70(C=S)174.89Fig. 6Inhibition diameter of ligands at 1 mg/mL.Fig. 6

2. Experimental design, materials, and methods {#sec2}
==============================================

Lauroyl chloride (3.272 g, 0.015 mol) and ammonium thiocyanate (1.142 g, 0.015 mol) were dissolved in acetone (25 mL) and stirred for an hour to give white precipitate. Then, β-alanine (1.336 g, 0.015 mol) was added dropwise and the mixture was heated at reflux until reaction was completed being filtered into ice. This was monitored by thin layer chromatography. The resulting solid was collected by filtration, washed with acetone and dried under vacuum to give 3-(3-dodecanoyl-thioureido)-propionic acid (R1). The synthesis of 2-(3-dodecanoyl-thioureido)-3-methyl-butyric acid (R2), (3-dodecanoyl-thioureido)-acetic acid (R3) and 2-(3-dodecanoyl-thioureido)-3-phenyl-propionic acid (R4) were prepared in similar manner as described for R1, employing [dl]{.smallcaps}-valine, glycine and [l]{.smallcaps}-phenylalanine as amino acid. The ligands were prepared following literature method described in the literature \[[@bib2]\]. The references are used as guidance in characterizing significant peaks from FTIR \[[@bib3]\] and ^1^H and ^13^C NMR spectra \[[@bib4],[@bib5]\].

The antibacterial activity of compounds R1-R4 were screened against test strains of Gram-positive (*Bacillus subtilis* ATCC 11774, *Staphylococcus epidermidis* ATCC 13518 and *Staphylococcus aureus* ATCC 25923) and Gram-negative (*Escherichia coli* ATCC 11775 and *Salmonella typhimurium* ATCC 14128) strains using common well diffusion method. Mueller-Hinton media were seeded with bacterial inoculum using cotton swab. Wells of 6.0 mm diameter were bored into the media using sterile cork borer and 90 μL of the diluted compounds at a dose range of 10--0.01 mg/mL were added in each well. Streptomycin (Abtek Biologicals Ltd) was used as the positive control while methanol served as negative control. All plates were incubated overnight at 37 °C. The antibacterial activity was evaluated by measuring the zone of inhibition (mm) and minimum inhibitory concentrations (MIC). Ligand that have high specific surface area structure gave higher antibacterial activity \[[@bib6]\].
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[^1]: \*In bracket: Theoretical Calculated Values.
